Frye D - Search Results

1

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: frye d. Clin Cancer Res. 2002 Nov;8(11):3360-8. Clin Cancer Res. 2002. PMID: 12429622 Clinical Trial.

2

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.

Rajan R, Poniecka A, Smith TL, Yang Y, Frye D, Pusztai L, Fiterman DJ, Gal-Gombos E, Whitman G, Rouzier R, Green M, Kuerer H, Buzdar AU, Hortobagyi GN, Symmans WF. Rajan R, et al. Among authors: frye d. Cancer. 2004 Apr 1;100(7):1365-73. doi: 10.1002/cncr.20134. Cancer. 2004. PMID: 15042669 Free article. Clinical Trial.

3

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.

Hanrahan EO, Broglio K, Frye D, Buzdar AU, Theriault RL, Valero V, Booser DJ, Singletary SE, Strom EA, Gajewski JL, Champlin RE, Hortobagyi GN. Hanrahan EO, et al. Among authors: frye d. Cancer. 2006 Jun 1;106(11):2327-36. doi: 10.1002/cncr.21906. Cancer. 2006. PMID: 16639731 Free article. Clinical Trial.

4

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.

Cristofanilli M, Gonzalez-Angulo AM, Buzdar AU, Kau SW, Frye DK, Hortobagyi GN. Cristofanilli M, et al. Clin Breast Cancer. 2004 Feb;4(6):415-9. doi: 10.3816/cbc.2004.n.004. Clin Breast Cancer. 2004. PMID: 15023242

5

Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.

Chedid S, Rivera E, Frye DK, Ibrahim N, Esteva F, Valero V, Hortobagyi G, Mettinger KL, Cristofanilli M. Chedid S, et al. Cancer Chemother Pharmacol. 2006 Apr;57(4):540-4. doi: 10.1007/s00280-005-0064-x. Epub 2005 Sep 29. Cancer Chemother Pharmacol. 2006. PMID: 16193332 Clinical Trial.

6

Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer.

Gonzalez-Angulo AM, Walters R, Broglio K, Frye DK, Strom EA, Theriault RL, Booser DJ, Valero V, Buzdar AU, Hortobagyi GN. Gonzalez-Angulo AM, et al. Clin Breast Cancer. 2008 Dec;8(6):516-21. doi: 10.3816/CBC.2008.n.063. Clin Breast Cancer. 2008. PMID: 19073507 Clinical Trial.

7

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.

Beinart GA, Gonzalez-Angulo AM, Broglio K, Frye D, Walters R, Holmes FA, Gunale S, Booser D, Rosenthal J, Dhingra K, Young JA, Hortobagyi GN. Beinart GA, et al. Among authors: frye d. Cancer Chemother Pharmacol. 2007 Jun;60(1):61-7. doi: 10.1007/s00280-006-0348-9. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009032 Clinical Trial.

8

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.

Arun BK, Dhinghra K, Valero V, Kau SW, Broglio K, Booser D, Guerra L, Yin G, Walters R, Sahin A, Ibrahim N, Buzdar AU, Frye D, Sneige N, Strom E, Ross M, Theriault RL, Vadhan-Raj S, Hortobagyi GN. Arun BK, et al. Among authors: frye d. Oncologist. 2011;16(11):1527-34. doi: 10.1634/theoncologist.2011-0134. Epub 2011 Oct 31. Oncologist. 2011. PMID: 22042783 Free PMC article. Clinical Trial.

9

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.

Abdayem P, Ghosn M, Valero V, Walters R, Arun B, Murray JL, Theriault R, Frye D, Ibrahim NK. Abdayem P, et al. Among authors: frye d. J Cancer. 2014 Mar 29;5(5):351-9. doi: 10.7150/jca.8304. eCollection 2014. J Cancer. 2014. PMID: 24723978 Free PMC article.

10

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: frye dk. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page